PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER

Introduction. The prognosis for surgical treatment of locally advanced gastric cancer remains disappointing. Neoadjuvant chemo-radiation therapy is relatively new and the least researched method of treatment, it is attracting more and more attention, mainly abroad in recent years. The aims of neoadj...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Yu. Skoropad, S. G. Afanasyev, S. V. Gamayunov, T. A. Agababyan, M. Yu. Volkov, S. A. Glushchenko, L. V. Evdokimov, K. S. Korchagina, S. A. Mozerov, O. A. Mikhaylova, N. O. Popova, G. O. Rukhadze, E. N. Samtsov, M. A. Safonova, A. A. Sveklova, Zh. A. Startseva, L. N. Titova, Z. K. Yakushina
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-07-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/328
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839579612187721728
author V. Yu. Skoropad
S. G. Afanasyev
S. V. Gamayunov
T. A. Agababyan
M. Yu. Volkov
S. A. Glushchenko
L. V. Evdokimov
K. S. Korchagina
S. A. Mozerov
O. A. Mikhaylova
N. O. Popova
G. O. Rukhadze
E. N. Samtsov
M. A. Safonova
A. A. Sveklova
Zh. A. Startseva
L. N. Titova
Z. K. Yakushina
author_facet V. Yu. Skoropad
S. G. Afanasyev
S. V. Gamayunov
T. A. Agababyan
M. Yu. Volkov
S. A. Glushchenko
L. V. Evdokimov
K. S. Korchagina
S. A. Mozerov
O. A. Mikhaylova
N. O. Popova
G. O. Rukhadze
E. N. Samtsov
M. A. Safonova
A. A. Sveklova
Zh. A. Startseva
L. N. Titova
Z. K. Yakushina
author_sort V. Yu. Skoropad
collection DOAJ
description Introduction. The prognosis for surgical treatment of locally advanced gastric cancer remains disappointing. Neoadjuvant chemo-radiation therapy is relatively new and the least researched method of treatment, it is attracting more and more attention, mainly abroad in recent years. The aims of neoadjuvant therapy is the earliest start of systemic therapy, damage of the primary tumor and regional metastases, an increase in the percentage of radical operations, improving treatment outcome. Material and methods. The planning study is a multicenter, randomized clinical phase II trial. Patients of the first (experimental) group will be treated as the followes: neoadjuvant chemo-radiotherapy (total tumor dose of 46 Gy in 23 fractions with the concurrent modified CapOX scheme) followed by D2 gastrectomy and adjuvant chemotherapy. Patients of the second (control) group will be treated with D2 gastrectomy and adjuvant chemotherapy. Adjuvant chemotherapy will be carried out under the following schemes (optional for the researchers): CapOX or FOLFOX. Toxicity evaluation of neoadjuvant chemo-radiotherapy and adjuvant chemotherapy will be conducted with NCI CTC Toxicity Scale Version 3.0. The main objectives of the trial are to assess the safety and immediate effectiveness of neoadjuvant chemo-radiotherapy according to the criteria of the frequency and severity of postoperative complications and mortality, and tumor response. We are planning to include 80 patients with morphologically confirmed gastric cancer сT2–4N1–3, сT3–4N0–3; М0. The proposed trial will be carried out in accordance with the principles of the Helsinki Declaration, it has been approved by local ethic committees of the participated institutions. Results. As a result of this multicenter randomized trial it is planned to show the reproducibility of obtained in MRRC and a number of foreign centers results – that is, the safety and high immediate effectiveness of neoadjuvant chemo-radiotherapy in patients with locally advanced gastric cancer. Conclusion. If we reach the goals of the planning trial, the results would allow to reasonably recommend the start of large international phase III trials for the final evaluation of the proposed neoadjuvant treatment as a standard one in patients with locally advanced gastric cancer.
format Article
id doaj-art-8d8d83a11e5d40d19c2dd8c2ecb86b28
institution Matheson Library
issn 1814-4861
2312-3168
language Russian
publishDate 2016-07-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-8d8d83a11e5d40d19c2dd8c2ecb86b282025-08-04T10:33:36ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682016-07-01152122010.21294/1814-4861-2016-15-2-12-20321PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCERV. Yu. Skoropad0S. G. Afanasyev1S. V. Gamayunov2T. A. Agababyan3M. Yu. Volkov4S. A. Glushchenko5L. V. Evdokimov6K. S. Korchagina7S. A. Mozerov8O. A. Mikhaylova9N. O. Popova10G. O. Rukhadze11E. N. Samtsov12M. A. Safonova13A. A. Sveklova14Zh. A. Startseva15L. N. Titova16Z. K. Yakushina17A.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Tomsk Cancer Research Institute, TomskRepublican Clinical Oncology Center, Ministry of Health of the Republic of Chuvashia, CheboksaryA.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Tomsk Cancer Research Institute, TomskTomsk Cancer Research Institute, TomskA.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Republican Clinical Oncology Center, Ministry of Health of the Republic of Chuvashia, CheboksaryA.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Republican Clinical Oncology Center, Ministry of Health of the Republic of Chuvashia, CheboksaryTomsk Cancer Research Institute, TomskA.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Tomsk Cancer Research Institute, TomskRepublican Clinical Oncology Center, Ministry of Health of the Republic of Chuvashia, CheboksaryRepublican Clinical Oncology Center, Ministry of Health of the Republic of Chuvashia, CheboksaryTomsk Cancer Research Institute, TomskA.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.A.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Korolev Street, 249031-Obninsk, Kaluga region, Russia.Introduction. The prognosis for surgical treatment of locally advanced gastric cancer remains disappointing. Neoadjuvant chemo-radiation therapy is relatively new and the least researched method of treatment, it is attracting more and more attention, mainly abroad in recent years. The aims of neoadjuvant therapy is the earliest start of systemic therapy, damage of the primary tumor and regional metastases, an increase in the percentage of radical operations, improving treatment outcome. Material and methods. The planning study is a multicenter, randomized clinical phase II trial. Patients of the first (experimental) group will be treated as the followes: neoadjuvant chemo-radiotherapy (total tumor dose of 46 Gy in 23 fractions with the concurrent modified CapOX scheme) followed by D2 gastrectomy and adjuvant chemotherapy. Patients of the second (control) group will be treated with D2 gastrectomy and adjuvant chemotherapy. Adjuvant chemotherapy will be carried out under the following schemes (optional for the researchers): CapOX or FOLFOX. Toxicity evaluation of neoadjuvant chemo-radiotherapy and adjuvant chemotherapy will be conducted with NCI CTC Toxicity Scale Version 3.0. The main objectives of the trial are to assess the safety and immediate effectiveness of neoadjuvant chemo-radiotherapy according to the criteria of the frequency and severity of postoperative complications and mortality, and tumor response. We are planning to include 80 patients with morphologically confirmed gastric cancer сT2–4N1–3, сT3–4N0–3; М0. The proposed trial will be carried out in accordance with the principles of the Helsinki Declaration, it has been approved by local ethic committees of the participated institutions. Results. As a result of this multicenter randomized trial it is planned to show the reproducibility of obtained in MRRC and a number of foreign centers results – that is, the safety and high immediate effectiveness of neoadjuvant chemo-radiotherapy in patients with locally advanced gastric cancer. Conclusion. If we reach the goals of the planning trial, the results would allow to reasonably recommend the start of large international phase III trials for the final evaluation of the proposed neoadjuvant treatment as a standard one in patients with locally advanced gastric cancer.https://www.siboncoj.ru/jour/article/view/328gastric cancerneoadjuvant chemo-radiotherapyd2 gastrectomyadjuvant chemotherapymulticenter randomized trial
spellingShingle V. Yu. Skoropad
S. G. Afanasyev
S. V. Gamayunov
T. A. Agababyan
M. Yu. Volkov
S. A. Glushchenko
L. V. Evdokimov
K. S. Korchagina
S. A. Mozerov
O. A. Mikhaylova
N. O. Popova
G. O. Rukhadze
E. N. Samtsov
M. A. Safonova
A. A. Sveklova
Zh. A. Startseva
L. N. Titova
Z. K. Yakushina
PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
Сибирский онкологический журнал
gastric cancer
neoadjuvant chemo-radiotherapy
d2 gastrectomy
adjuvant chemotherapy
multicenter randomized trial
title PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
title_full PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
title_fullStr PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
title_full_unstemmed PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
title_short PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
title_sort planning phase 2 multicenter randomized trial of neoadjuvant chemo radiotherapy followed by d2 gastrectomy and adjuvant chemotherapy for locally advanced gastric cancer
topic gastric cancer
neoadjuvant chemo-radiotherapy
d2 gastrectomy
adjuvant chemotherapy
multicenter randomized trial
url https://www.siboncoj.ru/jour/article/view/328
work_keys_str_mv AT vyuskoropad planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT sgafanasyev planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT svgamayunov planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT taagababyan planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT myuvolkov planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT saglushchenko planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT lvevdokimov planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT kskorchagina planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT samozerov planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT oamikhaylova planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT nopopova planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT gorukhadze planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT ensamtsov planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT masafonova planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT aasveklova planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zhastartseva planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT lntitova planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer
AT zkyakushina planningphase2multicenterrandomizedtrialofneoadjuvantchemoradiotherapyfollowedbyd2gastrectomyandadjuvantchemotherapyforlocallyadvancedgastriccancer